RLYB
Rallybio Corp
NASDAQ · Healthcare · Biotechnology · US
$17.19
+0.17%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+7.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 18, 2026 | Chung Wendy · director | M-Exempt | 3,562 | $2.38 |
| Jul 10, 2026 | Boudreau Helen M · director | M-Exempt | 3,562 | $2.38 |
| May 20, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 6,009 | $14 |
| May 20, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 10,000 | $14 |
| May 20, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 200 | $14 |
| May 15, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 4,081 | $14 |
| May 15, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 75,178 | $14 |
| May 15, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 100 | $14 |
| May 15, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 200 | $14 |
| May 13, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 5,100 | $14 |
| May 13, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 19,900 | $14 |
| May 13, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 800 | $14 |
| May 13, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 25,000 | $14 |
| May 6, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 3,900 | $14 |
| May 6, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 35,101 | $14 |
| May 6, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 116,904 | $14 |
| Feb 23, 2026 | Lieber Jonathan I · officer: Chief Financial Officer | A-Award | 2,500 | $0.00 |
| Feb 23, 2026 | Lieber Jonathan I · officer: Chief Financial Officer | Sale | 789 | $5.06 |
| Feb 20, 2026 | HUNT RONALD · director | A-Award | 14,305 | $4.45 |
| Feb 20, 2026 | MACKAY MARTIN · director | A-Award | 18,055 | $4.45 |
| May 15, 2025 | Chung Wendy · director | A-Award | 28,500 | $0.30 |
| May 15, 2025 | Hopfner Robert Lorne · director | A-Award | 28,500 | $0.30 |
| May 15, 2025 | Nash Christine A · director | A-Award | 28,500 | $0.30 |
| May 15, 2025 | Soteropoulos Paula · director | A-Award | 28,500 | $0.30 |
| May 15, 2025 | Boudreau Helen M · director | A-Award | 28,500 | $0.30 |
| May 15, 2025 | MACKAY MARTIN · director | A-Award | 28,500 | $0.30 |
| May 15, 2025 | Liu Hui · director | A-Award | 28,500 | $0.30 |
| May 15, 2025 | HUNT RONALD · director | A-Award | 28,500 | $0.30 |
| Feb 19, 2025 | Ryder Steven · officer: Chief Medical Officer | A-Award | 180,000 | $0.76 |
| Feb 19, 2025 | Lieber Jonathan I · officer: Chief Financial Officer | A-Award | 180,000 | $0.76 |
Institutional positioning
13F filings over the trailing two quarters
New 22Increased 11Reduced 30Sold out 10
| Filer | Action | Shares | Filed |
|---|---|---|---|
| ADAR1 Capital Management, LLC | Increased | 926,352 | Aug 14, 2026 |
| FMR LLC | Increased | 794,720 | Aug 13, 2026 |
| FMR LLC | Reduced | 793,451 | May 15, 2026 |
| VIKING GLOBAL INVESTORS LP | Unchanged | 524,347 | Aug 14, 2026 |
| VIKING GLOBAL INVESTORS LP | Reduced | 524,347 | May 15, 2026 |
| CORMORANT ASSET MANAGEMENT, LP | New Position | 400,000 | May 15, 2026 |
| TPG GP A, LLC | Unchanged | 378,551 | Aug 14, 2026 |
| TPG GP A, LLC | Reduced | 378,551 | May 15, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | New Position | 376,573 | May 15, 2026 |
| LAURION CAPITAL MANAGEMENT LP | New Position | 302,756 | May 14, 2026 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | New Position | 300,635 | May 15, 2026 |
| Pivotal bioVenture Partners Investment Advisor LLC | Unchanged | 300,579 | Aug 13, 2026 |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | Reduced | 300,579 | May 14, 2026 |
| 5AM VENTURE MANAGEMENT, LLC | Reduced | 291,788 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 199,907 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 18, 2026